OS for osimertinib vs placebo was 58.8 vs 54 months at the latest analysis of the phase 3 LAURA trial, according to ...

The interim results of a phase 3 trial of Merck’s pulmonary arterial hypertension (PAH) treatment Winrevair were so ...

We recently published a list of 14 AI News and Ratings Making Waves on Wall Street. In this article, we are going to take a ...

Patients taking sotatercept had a 76% relative risk reduction in morbidity and mortality events compared with patients taking ...

Gastric05 Phase 3 Trial of ENHERTU® Initiated in Patients with Previously Untreated HER2 Positive Advanced Gastric Cancer ...

Subcutaneous pembrolizumab reduces time demands for both the patient and clinician, all while providing a consistent efficacy ...

Alphabet, Oracle, ServiceNow, Salesforce, Merck & Co., Inc., UnitedHealth Group, and Vertiv are the seven Healthcare stocks ...

The current market uncertainty has sparked investor interest in exchange-traded funds and there are plenty to choose from.

The list ranks the top companies in the pharmaceutical industry by their global sales, as well as by their revenues in the US ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

No serious adverse events related to the drug were reported. "What we have is a drug that can lower lipoprotein(a) with very ...

Eli Lilly has linked lepodisiran to sustained reductions in a cardiovascular disease risk factor for nearly 1.5 years, bolstering the company’s argument that the siRNA candidate has an edge over ...